Quick answers
- What is JAYTHARI Oral Suspension?
- JAYTHARI Oral Suspension is a brand name of Deflazacort, a prescription medicine. The FDA NDC Directory lists 2 JAYTHARI Oral Suspension products in 1 strength and form.
- Who makes JAYTHARI Oral Suspension?
- Zydus Lifesciences holds the FDA application for JAYTHARI Oral Suspension (ANDA220042, approved October 3, 2025). 1 other company (repackagers or distributors) also list JAYTHARI Oral Suspension products.
- Is there a generic or store brand of JAYTHARI Oral Suspension?
- Yes. The FDA NDC Directory lists 8 other products with the same active ingredients, strength and form as a JAYTHARI Oral Suspension product, 7 of them generic. Ask your pharmacist whether one is right for you.
- Has JAYTHARI Oral Suspension been recalled?
- No recall linked to JAYTHARI Oral Suspension products (by their NDC code or label) appears in the FDA enforcement reports we use.
What JAYTHARI Oral Suspension is
Each JAYTHARI Oral Suspension product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Deflazacort · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| deflazacort 22.75 mg/mL suspension (oral) | JAYTHARI Oral Suspension | 8 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Deflazacort →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA220042 | Zydus Lifesciences | October 3, 2025 | 2 |
Companies that list JAYTHARI Oral Suspension
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of JAYTHARI Oral Suspension products.
- Doppel Farmaceutici S.r.l.1 product
- Zydus Pharmaceuticals (USA) Inc.1 product
Recalls
No recall linked to JAYTHARI Oral Suspension products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.